Study of genomes from patients with neurodevelopmental disorders:

- Patients for whom routine diagnostics have detected a structural variant classified as of unknown significance
- Development of protocols based on long-read sequencing using Oxford Nanopore technology
    - Whole genome sequencing protocol
    - Targeted sequencing (Adaptive sampling)
    - Transcriptome sequencing protocol
    - Barcode protocols